PERIPHERAL BLOOD TRANSCRIPTOMIC CORRELATION WITH CLINICAL TRAITS IN JUVENILE DERMATOMYOSITIS (JDM) AND THE ANTI-TIF1 MYOSITIS-SPECIFIC AUTOANTIBODY (MSA) GROUP

被引:0
|
作者
Zajmi, Ujana [1 ]
Darrell, Megan [1 ]
Kaneshiro, Amy M. [1 ]
Chin, Adeline [1 ]
de Jesus, Adriana A. [2 ]
Brooks, Stephen [3 ]
Goldbach-Mansky, Raphaela [2 ]
Rider, Lisa G. [4 ]
Kim, Hanna [1 ]
机构
[1] NIAMS, Juvenile Myositis Pathogenesis & Therapeut Unit, Pediat Translat Res Branch, NIH, Bethesda, MD USA
[2] NIAID, Translat Autoinflammatory Dis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD USA
[4] NIEHS, Environm Autoimmun Grp, Clin Res Branch, NIH, Bethesda, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-72
引用
收藏
页码:524 / 525
页数:2
相关论文
共 9 条
  • [1] PROTEOMIC ANALYSIS REVEALS DIFFERENT PROTEIN MODULES AND FUNCTIONAL ANNOTATIONS WITH CLINICAL TRAITS IN JUVENILE DERMATOMYOSITIS (JDM) AND MYOSITIS-SPECIFIC AUTOANTIBODY (MSA) GROUP (ANTI-TIF1 AUTOANTIBODY)
    Kaneshiro, Amy M.
    Chin, Adeline Y.
    Zajmi, Ujana
    Darrell, Megan P.
    Biancotto, Angelique
    Cheung, Foo
    Miller, Frederick W.
    Rider, Lisa G.
    Kim, Hanna
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 526 - 527
  • [2] Top Peripheral Blood Transcriptomic Gene Modules Reveal Functional Annotation and Correlation with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
    Zajmi, Ujana
    Darrell, Megan
    Kaneshiro, Amy
    Chin, Adeline
    Jesus, Adriana
    Brooks, Stephen
    Goldbach-Mansky, Raphaela
    Rider, Lisa
    Kim, Hanna
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3615 - 3617
  • [3] Broad Proteomic Analysis Reveals Top Differential Protein Modules and Functional Annotations with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
    Kaneshiro, Amy
    Chin, Adeline
    Rider, Lisa
    Miller, Frederick
    Cheung, Foo
    Darrell, Megan
    Biancotto, Angelique
    Zajmi, Ujana
    Kim, Hanna
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3631 - 3633
  • [4] Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy
    Ueda-Hayakawa, I.
    Hamaguchi, Y.
    Okiyama, N.
    Motegi, S.
    Yamaoka, T.
    Miyake, S.
    Higashi, A.
    Okamoto, H.
    Takehara, K.
    Fujimoto, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 881 - 887
  • [5] Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
    Takezaki, Daiki
    Onishi, Shuhei
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Kohzan, Hiroko
    Hamada, Toshihisa
    ACTA DERMATO-VENEREOLOGICA, 2020, 100
  • [6] A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing
    Mulhearn, Ben
    Li, Danyang
    McMorrow, Fionnuala
    Lu, Hui
    McHugh, Neil J.
    Tansley, Sarah L.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies
    Ueda-Hayakawa, Ikuko
    Tonomura, Kyoko
    Maekawa, Aya
    Kaneda, Emi
    Arase, Noriko
    Fujimoto, Manabu
    JOURNAL OF DERMATOLOGY, 2023, 50 (08): : 1058 - 1062
  • [8] Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital
    Takeshi Suga
    Hiroshi Oiwa
    Michihiro Ishida
    Yasuo Iwamoto
    Clinical Rheumatology, 2022, 41 : 2803 - 2808
  • [9] Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital
    Suga, Takeshi
    Oiwa, Hiroshi
    Ishida, Michihiro
    Iwamoto, Yasuo
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2803 - 2808